‘Shortage of reumamedicijn sulfasalazine threatens’
The Faculty warns for an impending shortage of the drug sulfasalazine. It is likely until march next year, limited availability.
That can lead to health risks for the 16,000 users, according to the Ruemafonds.
Sulfasalazine is relatively often used by pregnant women, because of the few side effects. To switch to another means indicates uncertainty: the new drug may cause side effects or my rheumatic complaints had can come back.
The Faculty calls upon the government and the manufacturer of sulfasalazine in order to take immediate measures.